Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been given a prescription for genetic testing related to ALS (or familial hypercholesterolemia, which is a hereditary cholesterol condition, if joining the control group)
- You have agreed and given your written consent to take part in the genetic study and to have your biological samples stored in a biobank
- You are covered by a health insurance plan
Who may not be able to join:
- You are currently under legal protection measures, such as being under the guardianship of the state or under a "safeguard of justice" order (a form of legal protection for people unable to manage their own affairs) (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Claire Guissart, CHU de Nimes
Phone: 04 66 68 32 07
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Concordance between the RNA-Seq results (index text) versus RT-PCR followed by Sanger sequencing (reference technique) on positive plus negative controls
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.